*In appropriate people 12 years and older. Talk with your doctor.
IDELVION is used to control and prevent bleeding episodes in children and adults with hemophilia B. Your doctor might also give you IDELVION before surgical procedures.
Zero median annualized spontaneous bleeding rate (AsBR) when dosed at 7 or 14 days in clinical trials
Elevates factor levels and keeps them there—21% with prophylactic use at steady state1,†‡
†Average FIX levels with 7-day dosing over 92 weeks in clinical trials.
‡Steady state is a consistent and uniform amount of factor in the body with continued use.
“Hemophilia: It’s not a wall, it’s a small hurdle.”
James Mitchell: IDELVION clinical trial participant
Get everything you need to know in the Welcome Kit. Receive news about IDELVION, hemophilia B, and assistance programs that may help you with treatment.Sign Up
Reference: 1. Data on file. Available from CSL Behring as DOF IDL-002.